TY - JOUR
T1 - Computational Fluid Dynamics and Additive Manufacturing to Diagnose and Treat Cardiovascular Disease
AU - Randles, Amanda
AU - Frakes, David
AU - Leopold, Jane A.
N1 - Funding Information:
The work reported in this publication was supported by the Office of the Director, National Institutes of Health under Award Number DP5OD019876 and NIH/NHLBI U01 HL125215. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This material is also based upon work supported by the National Science Foundation under Grant No. 1512553 . The authors thank Justin Ryan from Phoenix Children’s Hospital for his assistance and Howard Fried for his feedback and comments.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/11
Y1 - 2017/11
N2 - Noninvasive engineering models are now being used for diagnosing and planning the treatment of cardiovascular disease. Techniques in computational modeling and additive manufacturing have matured concurrently, and results from simulations can inform and enable the design and optimization of therapeutic devices and treatment strategies. The emerging synergy between large-scale simulations and 3D printing is having a two-fold benefit: first, 3D printing can be used to validate the complex simulations, and second, the flow models can be used to improve treatment planning for cardiovascular disease. In this review, we summarize and discuss recent methods and findings for leveraging advances in both additive manufacturing and patient-specific computational modeling, with an emphasis on new directions in these fields and remaining open questions. The improved capabilities of additive manufacturing in terms of material properties and resolution is opening new and exciting possibilities for the use of 3D printing in cardiovascular medicine. Methods for using high performance computing to enable high fidelity and patient-specific fluid simulations are rapidly evolving, providing new insights into the role hemodynamic forces play in cardiovascular disease. The emerging synergy between large-scale simulations and 3D printing is having a two-fold benefit: (i) 3D printing can be used to validate the complex simulations and (ii) the flow models can be used to improve treatment planning for cardiovascular disease.
AB - Noninvasive engineering models are now being used for diagnosing and planning the treatment of cardiovascular disease. Techniques in computational modeling and additive manufacturing have matured concurrently, and results from simulations can inform and enable the design and optimization of therapeutic devices and treatment strategies. The emerging synergy between large-scale simulations and 3D printing is having a two-fold benefit: first, 3D printing can be used to validate the complex simulations, and second, the flow models can be used to improve treatment planning for cardiovascular disease. In this review, we summarize and discuss recent methods and findings for leveraging advances in both additive manufacturing and patient-specific computational modeling, with an emphasis on new directions in these fields and remaining open questions. The improved capabilities of additive manufacturing in terms of material properties and resolution is opening new and exciting possibilities for the use of 3D printing in cardiovascular medicine. Methods for using high performance computing to enable high fidelity and patient-specific fluid simulations are rapidly evolving, providing new insights into the role hemodynamic forces play in cardiovascular disease. The emerging synergy between large-scale simulations and 3D printing is having a two-fold benefit: (i) 3D printing can be used to validate the complex simulations and (ii) the flow models can be used to improve treatment planning for cardiovascular disease.
KW - 3D printing
KW - additive manufacturing
KW - cardiovascular disease
KW - computational fluid dynamics
KW - high-performance computing
UR - http://www.scopus.com/inward/record.url?scp=85029630208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029630208&partnerID=8YFLogxK
U2 - 10.1016/j.tibtech.2017.08.008
DO - 10.1016/j.tibtech.2017.08.008
M3 - Review article
C2 - 28942268
AN - SCOPUS:85029630208
SN - 0167-7799
VL - 35
SP - 1049
EP - 1061
JO - Trends in Biotechnology
JF - Trends in Biotechnology
IS - 11
ER -